MSD Health Award for innovation and higher quality of treatment
13.09.2018 10:49
For the seventh time, the research-based pharmaceutical company MSD has honored innovative and groundbreaking care projects with the MSD Health Prize. A prominent jury selected seven supply projects from 64 applications and honored them with prize money totaling 110,000 euros. For the first time this year, an audience prize of 5,000 euros was awarded.
Melanie Huml, Bavarian State Minister for Health and Care, took over the patronage: “The MSD Health Prize is not only an award for selected projects, but also an incentive for others to also put their ideas into practice. The range of participants allows us to look beyond our own horizons. Through mutual exchange, fruitful solutions emerge that advance our entire health system and help the people in our country.”
The number of applicant projects reflects the need for innovative care solutions: According to the pharmaceutical company, 64 initiatives applied for the MSD Health Prize 2018. Ten projects made it to the final round, from which the jury selected seven winners.
The jury decisions at a glance:
– Rank 1 and Medical or Organizational Breakthrough Innovation / Lighthouse Project: Helios Klinikum Berlin-Buch, Ulm University Hospital: National Second Opinion Project Testicular Tumor
– Rank 2: MuM, Medicine and More eG: elVi – The electronic visit
– Rank 3: Greifwald University Medical Center, Clinic for Anesthesiology: Sepsis Dialogue
– Rank 3: University Hospital Frankfurt, KAIS: Patient Blood Management
– Special prize for e-health/digitalization: VFTH eV and Rösch & Associates GmbH.: smart medicationTM
– Special prize for community medicine/doctor networks: Caritasverband Hannover eV: street ambulance
– Special prize for strengthening patient participation/adherence: Munich Ambulatory Children’s Hospice Foundation
The jury winner
This year's first place went to the “National Second Opinion Project Testicular Tumor” project, a lighthouse project for case-related second expertise. According to MSD, the second opinion network for testicular tumors is an online consultation system with which urologists can obtain advice from a specialized second opinion center when planning therapy. “The MSD Health Prize is a great recognition and enables us to further expand our self-image for this process,” said a pleased Prof. Dr. med. Mark Schrader, head of the testicular tumor second opinion project.
The audience award
For the first time, all ten finalists were up for election for the audience award. This gives all those who should benefit from the solutions a voice. 4,813 users voted online for their favorite. The winner is the “Sepsis Dialogue” of the Greifwald University Medical Center and the Clinic for Anesthesiology, a quality management approach that can save lives through rapid diagnostics and education.